Profound Medical PROF Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 71.1%+3.4pp | 70.8%+4.9pp | 72.5%+10.4pp | 69.4%— | 67.6%— | |
| Operating margin | -202.6%+104pp | -256.3%+53.3pp | -295.4%+88.5pp | -357.4%— | -306.4%— | |
| Net margin | -206.8%+62.6pp | -264.4%-4.0pp | -275.2%+85.5pp | -344%— | -269.4%— | |
| Returns | ||||||
| Return on equity | -70.6%— | -67.1%— | -125.2%— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 6.6×— | 12.5×— | 4.2×— | —— | —— | |
| Leverage | ||||||
| Debt-to-equity | 0.1×— | 0.1×— | 0.1×— | —— | —— | |
| Per Share | ||||||
| Book value per share | $1.64-3.2% | $2.20-9.9% | $1.07-14.7% | $1.31— | $1.69— | |
| Valuation | ||||||
| Market capitalization | $241.65M+30.7% | $278.37M+23.4% | $146.96M-24.6% | $186.33M-9.1% | $174.83M-16.1% | |
| Price / sales | 12.8×-2.8× | 17.3×-3.8× | 10.3×-13.2× | 15.7×— | 14.7×— | |
| Price / book | 4.1×-0.6× | 4.2×+0.5× | 4.6×-1.8× | 4.7×— | 3.4×— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Profound Medical's profit margins?
- Profound Medical (PROF) runs a 71.1% gross margin and a -202.6% operating margin, with a -206.8% net margin.
- Where do Profound Medical's ratios come from?
- Every ratio is computed from Profound Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
